{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:12:11Z","timestamp":1795072331476,"version":"4.10.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"crossref","award":["MDA549004"],"award-info":[{"award-number":["MDA549004"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U54-AR-052646"],"award-info":[{"award-number":["U54-AR-052646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Duchenne muscular dystrophy (DMD) is an X-linked, lethal muscle degenerative disease caused by loss of dystrophin protein. DMD has no cure and few treatment options. Preclinical efforts to identify potential DMD therapeutics have been hampered by lack of a small animal model that recapitulates key features of the human disease. While the dystrophin-deficient\n                    <jats:italic>mdx<\/jats:italic>\n                    mouse on the C57BL\/10 genetic background (B10.\n                    <jats:italic>mdx<\/jats:italic>\n                    ) is mildly affected, a more severe muscle disease is observed when the\n                    <jats:italic>mdx<\/jats:italic>\n                    mutation is crossed onto the DBA\/2J genetic background (D2.\n                    <jats:italic>mdx<\/jats:italic>\n                    ). In this study, the functional and histological progression of the D2.\n                    <jats:italic>mdx<\/jats:italic>\n                    skeletal muscle pathology was evaluated to determine the distinguishing features of disease. Data herein details the muscular weakness and wasting exhibited by D2.\n                    <jats:italic>mdx<\/jats:italic>\n                    skeletal muscle, as well as severe histopathological features, which include the rapid progression of fibrosis and calcifications in the diaphragm and progressive fibrosis accumulation in limb muscles. Furthermore, a timeline of D2.\n                    <jats:italic>mdx<\/jats:italic>\n                    progression is provided that details distinct stages of disease progression. These data support the D2.\n                    <jats:italic>mdx<\/jats:italic>\n                    as a superior small animal model for DMD, as compared to the B10.\n                    <jats:italic>mdx<\/jats:italic>\n                    model. The insights provided in this report should facilitate the design of preclinical evaluations for potential DMD therapeutics.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-70987-y","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T06:44:26Z","timestamp":1597992266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy"],"prefix":"10.1038","volume":"10","author":[{"given":"David W.","family":"Hammers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora C.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Matheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Armellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth R.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Lee","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"70987_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman, E. P., Brown, R. H. Jr. & Kunkel, L. M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919\u2013928 (1987).","journal-title":"Cell"},{"key":"70987_CR2","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M. & Sweeney, H. L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. U. S. A. 90, 3710\u20133714 (1993).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"70987_CR3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.bbapap.2010.05.001","volume":"1713\u20131722","author":"E Le Rumeur","year":"1804","unstructured":"Le Rumeur, E., Winder, S. J. & Hubert, J. F. Dystrophin: More than just the sum of its parts. Biochim. Biophys. Acta 1713\u20131722, 2010. https:\/\/doi.org\/10.1016\/j.bbapap.2010.05.001 (1804).","journal-title":"Biochim. Biophys. Acta"},{"key":"70987_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/hmg\/ddv460","volume":"25","author":"WD Coley","year":"2016","unstructured":"Coley, W. D. et al. Effect of genetic background on the dystrophic phenotype in mdx mice. Hum. Mol. Genet. 25, 130\u2013145. https:\/\/doi.org\/10.1093\/hmg\/ddv460 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"70987_CR5","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","volume":"176","author":"S Fukada","year":"2010","unstructured":"Fukada, S. et al. Genetic background affects properties of satellite cells and mdx phenotypes. Am. J. Pathol. 176, 2414\u20132424. https:\/\/doi.org\/10.2353\/ajpath.2010.090887 (2010).","journal-title":"Am. J. Pathol."},{"key":"70987_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135703","author":"DA Mazala","year":"2020","unstructured":"Mazala, D. A. et al. TGF-beta-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.135703 (2020).","journal-title":"JCI Insight."},{"key":"70987_CR7","doi-asserted-by":"publisher","first-page":"38371","DOI":"10.1038\/srep38371","volume":"6","author":"M Rodrigues","year":"2016","unstructured":"Rodrigues, M. et al. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA\/2 background. Sci. Rep.. 6, 38371. https:\/\/doi.org\/10.1038\/srep38371 (2016).","journal-title":"Sci. Rep.."},{"key":"70987_CR8","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1172\/JCI39845","volume":"119","author":"A Heydemann","year":"2009","unstructured":"Heydemann, A. et al. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J. Clin. Investig. 119, 3703\u20133712. https:\/\/doi.org\/10.1172\/JCI39845 (2009).","journal-title":"J. Clin. Investig."},{"key":"70987_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.23819","volume":"73","author":"KM Flanigan","year":"2013","unstructured":"Flanigan, K. M. et al. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann. Neurol. 73, 481\u2013488. https:\/\/doi.org\/10.1002\/ana.23819 (2013).","journal-title":"Ann. Neurol."},{"key":"70987_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133276","author":"DW Hammers","year":"2020","unstructured":"Hammers, D. W. et al. Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.133276 (2020).","journal-title":"JCI Insight."},{"key":"70987_CR11","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1172\/JCI91445","volume":"127","author":"M Quattrocelli","year":"2017","unstructured":"Quattrocelli, M. et al. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J. Clin. Investig. 127, 2418\u20132432. https:\/\/doi.org\/10.1172\/JCI91445 (2017).","journal-title":"J. Clin. Investig."},{"key":"70987_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.omtm.2017.06.006","volume":"6","author":"CH Hakim","year":"2017","unstructured":"Hakim, C. H. et al. A five-repeat micro-dystrophin gene ameliorated dystrophic phenotype in the severe DBA\/2J-mdx model of duchenne muscular dystrophy. Mol. Ther. Methods Clin. Dev. 6, 216\u2013230. https:\/\/doi.org\/10.1016\/j.omtm.2017.06.006 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"70987_CR13","doi-asserted-by":"publisher","first-page":"e0147198","DOI":"10.1371\/journal.pone.0147198","volume":"11","author":"D Hardy","year":"2016","unstructured":"Hardy, D. et al. Comparative study of injury models for studying muscle regeneration in mice. PLoS ONE 11, e0147198. https:\/\/doi.org\/10.1371\/journal.pone.0147198 (2016).","journal-title":"PLoS ONE"},{"key":"70987_CR14","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1096\/fj.201802488R","volume":"33","author":"M van Putten","year":"2019","unstructured":"van Putten, M. et al. Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy. FASEB J. 33, 8110\u20138124. https:\/\/doi.org\/10.1096\/fj.201802488R (2019).","journal-title":"FASEB J."},{"key":"70987_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/BF02253356","volume":"5","author":"T Totsuka","year":"1998","unstructured":"Totsuka, T., Watanabe, K., Uramoto, I., Sakuma, K. & Mizutani, T. Muscular dystrophy: Centronucleation may reflect a compensatory activation of defective myonuclei. J. Biomed. Sci. 5, 54\u201361. https:\/\/doi.org\/10.1007\/BF02253356 (1998).","journal-title":"J. Biomed. Sci."},{"key":"70987_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s004210050176","volume":"75","author":"AX Bigard","year":"1997","unstructured":"Bigard, A. X., Merino, D., Lienhard, F., Serrurier, B. & Guezennec, C. Y. Quantitative assessment of degenerative changes in soleus muscle after hindlimb suspension and recovery. Eur. J. Appl. Physiol. Occup. Physiol. 75, 380\u2013387. https:\/\/doi.org\/10.1007\/s004210050176 (1997).","journal-title":"Eur. J. Appl. Physiol. Occup. Physiol."},{"key":"70987_CR17","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","volume":"26","author":"D Duan","year":"2018","unstructured":"Duan, D. Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy. Mol. Ther. 26, 2337\u20132356. https:\/\/doi.org\/10.1016\/j.ymthe.2018.07.011 (2018).","journal-title":"Mol. Ther."},{"key":"70987_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/14712598.2017.1271872","volume":"17","author":"EH Niks","year":"2017","unstructured":"Niks, E. H. & Aartsma-Rus, A. Exon skipping: A first in class strategy for Duchenne muscular dystrophy. Expert Opin. Biol. Ther. 17, 225\u2013236. https:\/\/doi.org\/10.1080\/14712598.2017.1271872 (2017).","journal-title":"Expert Opin. Biol. Ther."},{"key":"70987_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/352536a0","volume":"352","author":"HH Stedman","year":"1991","unstructured":"Stedman, H. H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536\u2013539. https:\/\/doi.org\/10.1038\/352536a0 (1991).","journal-title":"Nature"},{"key":"70987_CR20","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1074\/jbc.R400029200","volume":"280","author":"DB Rifkin","year":"2005","unstructured":"Rifkin, D. B. Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability. J. Biol. Chem. 280, 7409\u20137412. https:\/\/doi.org\/10.1074\/jbc.R400029200 (2005).","journal-title":"J. Biol. Chem."},{"key":"70987_CR21","doi-asserted-by":"publisher","first-page":"e0121556","DOI":"10.1371\/journal.pone.0121556","volume":"10","author":"A Gonzalez-Barriga","year":"2015","unstructured":"Gonzalez-Barriga, A. et al. Cell membrane integrity in myotonic dystrophy type 1: Implications for therapy. PLoS ONE 10, e0121556. https:\/\/doi.org\/10.1371\/journal.pone.0121556 (2015).","journal-title":"PLoS ONE"},{"key":"70987_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2990.1988.tb00866.x","volume":"14","author":"GR Coulton","year":"1988","unstructured":"Coulton, G. R., Morgan, J. E., Partridge, T. A. & Sloper, J. C. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol. Appl. Neurobiol. 14, 53\u201370. https:\/\/doi.org\/10.1111\/j.1365-2990.1988.tb00866.x (1988).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"70987_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0960-8966(93)90098-5","volume":"3","author":"JP Louboutin","year":"1993","unstructured":"Louboutin, J. P., Fichter-Gagnepain, V., Thaon, E. & Fardeau, M. Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscul. Disord. 3, 463\u2013469. https:\/\/doi.org\/10.1016\/0960-8966(93)90098-5 (1993).","journal-title":"Neuromuscul. Disord."},{"key":"70987_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.201402079","volume":"207","author":"S Dadgar","year":"2014","unstructured":"Dadgar, S. et al. Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. J. Cell Biol. 207, 139\u2013158. https:\/\/doi.org\/10.1083\/jcb.201402079 (2014).","journal-title":"J. Cell Biol."},{"key":"70987_CR25","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/NEN.0b013e3181aa31c2","volume":"68","author":"I Desguerre","year":"2009","unstructured":"Desguerre, I. et al. Endomysial fibrosis in Duchenne muscular dystrophy: A marker of poor outcome associated with macrophage alternative activation. J. Neuropathol. Exp. Neurol. 68, 762\u2013773. https:\/\/doi.org\/10.1097\/NEN.0b013e3181aa31c2 (2009).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"70987_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/mus.24998","volume":"54","author":"LR Smith","year":"2016","unstructured":"Smith, L. R., Hammers, D. W., Sweeney, H. L. & Barton, E. R. Increased collagen cross-linking is a signature of dystrophin-deficient muscle. Muscle Nerve 54, 71\u201378. https:\/\/doi.org\/10.1002\/mus.24998 (2016).","journal-title":"Muscle Nerve"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70987-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70987-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70987-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:18:32Z","timestamp":1670329112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70987-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70987"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70987-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14070"}}